Navigation Links
Data Related to Chimerix's Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
Date:2/4/2013

RESEARCH TRIANGLE PARK, N.C., Feb. 4, 2013 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company developing antivirals in areas of high unmet medical need, today announced that three abstracts related to the broad-spectrum antiviral compound CMX001 will be presented at the BMT Tandem Meetings being held February 13-17 in Salt Lake City.  The BMT Tandem Meetings are the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and Marrow Transplantation (ASBMT).  

Chimerix's presentations on CMX001 address the emerging safety profile of the compound and early clinical data on its activity against BK virus, and will be presented on Saturday, February 16 from 7:00 am to 5:00 pm MT:

Renal Safety of Broad Spectrum Antiviral CMX001 in the Prevention of CMV Infection Post‐Allogeneic Hematopoietic Cell Transplantation (HCT)

Monitoring Changes in Serum Albumin (SA) Concentrations as an Early and Objective Indicator of Potential CMX001‐Associated Gastrointestinal (GI) Adverse Drug Effects  

BK Virus‐Associated Nephropathy (BKVN), an Under‐Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of BKVN and the Potential Role of CMX001 for Treatment  

For more information, please see the BMT Tandem Meetings website:  http://www.asbmt.org/displaycommon.cfm?an=3.

About Chimerix and CMX001
Chimerix is committed to the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of high unmet medical need.  The Company's proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 an
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. In Preventing Diabetes-Related Heart Disease, Blood Pressure and Cholesterol Targets are Higher Priorities than Blood Sugar
2. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
3. Atonomics Achieves Significant Milestone Related to Performance Data for Troponin I Assay Triggering Scheduled Payments From Beckman Coulter
4. Exercise Rate Related to Improvements in Parkinsons Disease
5. Analysis Finds Improvements in Health-Related Quality of Life for Hereditary Angioedema Patients Treated with C1-Inhibitor
6. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
7. New "15 Every Hour" Campaign Spreads the Word on the Devastating Impact of AFib-Related Stroke
8. Call for Submissions: ICAP Patent Brokerage Announces Expansion of Life Sciences Practice and Increased Buyer Interest in Related Intellectual Property
9. Abbott Sued for False Claims Related to its Blockbuster Drug TriCor
10. PDI, Inc. Announces Client FDA Product Approval Related to Previously Disclosed Contract
11. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma ... diagnosed victims of mesothelioma get the best possible ... certain individuals with this rare cancer caused by ... most up-to-date information related to treatment options such ... please call the Mesothelioma Victims Center anytime at ...
(Date:5/22/2015)... , May 22, 2015 Research and Markets ... addition of the "Latest Regulations on Pharmaceutical ... to their offering. This is first ... a guidance on international multi-center clinical trials of ... has begun to be implemented on March 1, ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... CALGARY, Alberta, July 27, 2011 Fero Industries, Inc. ... Merck S.A. de C.V. has increased its Sucanon® promotional ...  Four tablet sample packages of Sucanon® will be provided ... to raise awareness and encourage long-term customer acceptance of ...
... VALLEY, Md., July 27, 2011 Pharmaceutics International, Inc. ... announced  that it has added hot melt extrusion (HME) ... The company has purchased a 16mm and an 18mm ... carry out feasibility studies, using just a few grams ...
Cached Medicine Technology:Fero Industries Increases Sucanon® Promotion in Mexico with Physician Distributed Sample Packages 2Fero Industries Increases Sucanon® Promotion in Mexico with Physician Distributed Sample Packages 3Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology 2
(Date:5/22/2015)... May 22, 2015 Omar Ahmad Barrada, ... to participate in the 2015 Congress of Future Medical ... as a gathering of “America’s highest achieving high school ... of healthcare, set new goals and learn better study ... live surgery, during which we can ask the surgeons ...
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and ... Dr. LaSalle D. Leffall, on Monday, May 18, with ... Grand Rounds in the hospital’s Tower Auditorium. Leffall’s younger ... auditorium, trying to keep the secret. “I’d like to ... me, he’ll know something is up,” she said. , ...
(Date:5/22/2015)... 2015 According to a new Aegis Living ... equally as likely to worry about what will happen to ... 77% Boomers, 69% Silent Generation), which may help explain why ... of aging, particularly Millennials (47%), Gen X’ers (51%), and Boomers ... April, 2015 among more than 2,000 U.S. adults ages 18+. ...
(Date:5/22/2015)... According to Berks and Beyond , Pennsylvania has ... almost 2,500 confirmed drug deaths, as reported on May 7th. ... deaths stemming from legal and illegal drug use in 2014. ... day to fatal overdoses or other drug related deaths. The ... the most rife with drug related deaths. The city, along ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... 16th sweetFrog store located in the Lone Star State. The ... Inc. 500 list of fastest growing companies in 2014. ... for 20 years and love the natural beauty and friendly ... Palestine, sweetFrog locations. “We are really excited about giving back ...
Breaking Medicine News(10 mins):Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2
... Administration (FDA) has accepted for filing the ... Neupro(R), (Rotigotine Transdermal System) as adjunctive therapy ... adult patients with advanced-stage Parkinson,s disease, ... New Drug Application (sNDA) for the use of Neupro(R) ...
... after drug-eluting stents is key, DALLAS, ... important after implanting a drug-eluting stent to ... joint Guidelines for Percutaneous,Coronary Intervention from the ... Society for Cardiovascular Angiography and,Interventions. The guidelines ...
... of us at Edward are proud,of CEO Pam Davis ... helping,federal authorities expose this corruption. Yet today,s indictment of ... more than four years,since Edward first filed an application ... hospital in Plainfield. The people of Plainfield,and surrounding areas ...
... Poll Shows Rural Seniors Want E-Prescribing in Medicare, ... so many issues, promoting electronic prescribing (e-prescribing) in,Medicare ... and Democrats can,agree on. "The Medicare Electronic Medication ... require that Medicare physicians begin to,prescribe electronically, will ...
... in on a DNA cluster that may encourage the ... carrying what,s known as a haplotype of a particular ... new study finds. , Haplotypes are clusters of genetic ... University of Kansas Medical Center (UKMC)collected blood samples and ...
... Decisions When Choosing,Nutritional Products, ANN ARBOR, ... steroid use in sports continue to emphasize ... nutrition products for banned,substances. NSF International,s Athletic ... athletes, coaches, trainers and anyone,concerned about banned ...
Cached Medicine News:Health News:Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease 2Health News:Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease 3Health News:Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease 4Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 2Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 3Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 4Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 5Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 2Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 3Health News:Genetics May Boost Mexican-Americans' Risk for Alcoholism 2Health News:Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances 2Health News:Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: